DK1418933T3 - Fremgangsmåde til fremstilling af glycopeptidphosphonatderivater - Google Patents

Fremgangsmåde til fremstilling af glycopeptidphosphonatderivater

Info

Publication number
DK1418933T3
DK1418933T3 DK02761475T DK02761475T DK1418933T3 DK 1418933 T3 DK1418933 T3 DK 1418933T3 DK 02761475 T DK02761475 T DK 02761475T DK 02761475 T DK02761475 T DK 02761475T DK 1418933 T3 DK1418933 T3 DK 1418933T3
Authority
DK
Denmark
Prior art keywords
preparation
phosphonate derivatives
glycopeptide phosphonate
glycopeptide
derivatives
Prior art date
Application number
DK02761475T
Other languages
English (en)
Inventor
Michael Leadbetter
Junning Lee
Jyanwei Liu
Martin Linsell
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Application granted granted Critical
Publication of DK1418933T3 publication Critical patent/DK1418933T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK02761475T 2001-08-24 2002-08-23 Fremgangsmåde til fremstilling af glycopeptidphosphonatderivater DK1418933T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31483101P 2001-08-24 2001-08-24
PCT/US2002/026853 WO2003029270A2 (en) 2001-08-24 2002-08-23 Process for preparing glycopeptide phosphonate derivatives

Publications (1)

Publication Number Publication Date
DK1418933T3 true DK1418933T3 (da) 2007-06-11

Family

ID=23221639

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02761475T DK1418933T3 (da) 2001-08-24 2002-08-23 Fremgangsmåde til fremstilling af glycopeptidphosphonatderivater

Country Status (15)

Country Link
US (5) US6979723B2 (da)
EP (1) EP1418933B1 (da)
JP (2) JP4116555B2 (da)
KR (1) KR100909438B1 (da)
CN (1) CN1246036C (da)
AT (1) ATE361312T1 (da)
AU (1) AU2002326739B2 (da)
BR (1) BRPI0211997B8 (da)
CA (1) CA2457863C (da)
DE (1) DE60219927T2 (da)
DK (1) DK1418933T3 (da)
ES (1) ES2286274T3 (da)
NO (1) NO331661B1 (da)
TW (1) TWI275594B (da)
WO (1) WO2003029270A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA75083C2 (uk) * 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
TWI275594B (en) * 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
WO2003106399A2 (en) 2002-06-17 2003-12-24 Theravance, Inc. PROCESS FOR PREPARING N-PROTECTED β-AMINO ALDEHYDE COMPOUNDS
TWI342312B (en) 2003-10-22 2011-05-21 Theravance Inc Hydrochloride salts of a glycopeptide phosphonate derivative
WO2013034675A1 (en) 2011-09-09 2013-03-14 Sandoz Ag Process for the synthesis of telavancin and its pharmaceutically acceptable salts as well as n-protected derivatives thereof
WO2013034676A1 (en) 2011-09-09 2013-03-14 Sandoz Ag Process for the synthesis of telavancin, its pharmaceutically acceptable salts as well as an n-protected imine-derivative of telavancin
WO2016063246A1 (en) * 2014-10-22 2016-04-28 Sun Pharmaceutical Industries Limited Crystalline form r of tedizolid phosphate
MX2017010837A (es) 2015-02-23 2017-12-07 Theravance Biopharma Antibiotics Ip Llc Dosis y metodos para administrar telavancina.
CN106467570B (zh) * 2015-08-14 2020-04-07 正大天晴药业集团股份有限公司 糖肽类抗生素的还原烷基化方法
CN106631902A (zh) * 2016-09-23 2017-05-10 上海步越化工科技有限公司 一种特拉万星侧链癸基(2‑氧代乙基)氨基甲酸9h‑芴‑9‑甲基酯的制备方法
CN107629115B (zh) * 2017-09-08 2021-05-07 福建省微生物研究所 一种特拉万星的纯化方法
CN107629116B (zh) * 2017-09-08 2021-05-07 福建省微生物研究所 一种特拉万星的纯化方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3160632A (en) 1961-01-30 1964-12-08 Stauffer Chemical Co Aminomethylenephosphinic acids, salts thereof, and process for their production
US4643967A (en) * 1983-07-07 1987-02-17 Bryant Bernard J Antibody method for lowering risk of susceptibility to HLA-associated diseases in future human generations
US4698327A (en) 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
IL78597A0 (en) 1985-04-25 1986-08-31 Lilly Co Eli Novel glycopeptide derivatives
US4643987A (en) 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
ES2083374T3 (es) 1988-12-27 1996-04-16 Lepetit Spa Derivados amidicos en posicion c63 de 34-des(acetilglucosaminil)-34-desoxi-teicoplaninas.
CA2031803C (en) 1989-12-13 2001-05-29 Ramakrishnan Nagarajan Improvements in or relating to glycopeptide deriveratives
US5750509A (en) 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
CA2109601C (en) 1991-07-29 2002-07-02 Adriano Malabarba Amide derivatives of antibiotic a 40926
US5840684A (en) 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
AU703106B2 (en) 1994-01-28 1999-03-18 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5561714A (en) * 1994-12-12 1996-10-01 Tektronix, Inc. Scrambling system for serial digital video
US5919756A (en) 1996-06-28 1999-07-06 Eli Lilly And Company Amides
US5939382A (en) 1996-11-21 1999-08-17 Eli Lilly And Company Reducing agent for reductive alkylation of glycopeptide antibiotics
US5952466A (en) 1997-11-12 1999-09-14 Eli Lilly And Company Reductive alkylation of glycopeptide antibiotics
US5916873A (en) 1997-04-17 1999-06-29 Eli Lilly And Company Teicoplanin derivatives
EP1060189A1 (en) 1998-02-20 2000-12-20 Advanced Medicine, Inc. Derivatives of glycopeptide antibacterial agents
US6518242B1 (en) 1998-02-20 2003-02-11 Theravance, Inc. Derivatives of glycopeptide antibacterial agents
HU230190B1 (hu) * 1998-12-23 2015-09-28 Theravance, Inc Glikopeptidszármazékok és ezeket tartalmazó gyógyászati kompozíciók
JP2000281694A (ja) * 1999-03-29 2000-10-10 Tanaka Kikinzoku Kogyo Kk 有機金属気相エピタキシー用の有機金属化合物
AU4054900A (en) 1999-04-02 2000-10-23 Advanced Medicine East, Inc. Desleucyl glycopeptide antibiotics and methods of making same
KR100856479B1 (ko) * 2000-05-02 2008-09-04 세라밴스 인코포레이티드 환원성 알킬화 방법
SI1278549T1 (sl) * 2000-05-02 2009-04-30 Theravance Inc Sestavek, ki vsebuje ciklodekstrin in glikopeptidni antibiotik
US6828299B2 (en) * 2000-06-22 2004-12-07 Theravance, Inc. Polyhydroxy glycopeptide derivatives
UA75083C2 (uk) * 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
KR20020013174A (ko) * 2000-08-11 2002-02-20 민경윤 경구 흡수율이 낮은 약물의 흡수율을 증가시키기 위한경구용 조성물
TWI275594B (en) * 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
US7726104B2 (en) * 2006-06-21 2010-06-01 Cp Packaging, Inc. Vacuum packaging system with end cutter

Also Published As

Publication number Publication date
DE60219927T2 (de) 2008-01-17
JP2008208130A (ja) 2008-09-11
EP1418933A2 (en) 2004-05-19
WO2003029270A3 (en) 2003-09-04
DE60219927D1 (de) 2007-06-14
CA2457863C (en) 2012-01-03
JP2005526000A (ja) 2005-09-02
ES2286274T3 (es) 2007-12-01
KR20040028999A (ko) 2004-04-03
US20030069391A1 (en) 2003-04-10
BR0211997A (pt) 2006-04-04
JP4116555B2 (ja) 2008-07-09
US7301004B2 (en) 2007-11-27
US7728104B2 (en) 2010-06-01
CA2457863A1 (en) 2003-04-10
US20110060122A1 (en) 2011-03-10
CN1246036C (zh) 2006-03-22
US20060264607A1 (en) 2006-11-23
US7074890B2 (en) 2006-07-11
BRPI0211997B8 (pt) 2016-11-16
TWI275594B (en) 2007-03-11
NO331661B1 (no) 2012-02-20
WO2003029270A2 (en) 2003-04-10
US20050020488A1 (en) 2005-01-27
AU2002326739B2 (en) 2007-10-18
US8093354B2 (en) 2012-01-10
US6979723B2 (en) 2005-12-27
BRPI0211997B1 (pt) 2016-10-11
EP1418933B1 (en) 2007-05-02
ATE361312T1 (de) 2007-05-15
US20080227963A1 (en) 2008-09-18
CN1547481A (zh) 2004-11-17
NO20040766L (no) 2004-04-29
KR100909438B1 (ko) 2009-07-28
EP1418933A4 (en) 2004-10-27

Similar Documents

Publication Publication Date Title
DK0828717T3 (da) Fremgangsmåde til fremstilling af 3-haloalkyl-1H-pyrazol
DK1418933T3 (da) Fremgangsmåde til fremstilling af glycopeptidphosphonatderivater
DK1404821T3 (da) Fremgangsmåde til fremstilling af L-aminosyrer under avnendelse af stammer fra familien Enterobacteriaceae
NO20050090L (no) Fremgangsmate for fremstilling av et virus-inaktivert trombinpreparat
IL140419A0 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
AU1613601A (en) Cleaning process which uses ultrasonic waves
ATE288758T1 (de) Verfahren zur herstellung von polymorphen des clarithromycins
AU1613801A (en) Cleaning process which uses ultrasonic waves
DK1419174T3 (da) Fremgangsmåde til fremstilling af glycopeptidderivater
DK1325022T3 (da) Fremgangsmåde til fremstilling af 21-hydroxy-6,19-oxidoprogesteron (21OH-6OP)
TR200403039T1 (tr) Seramik parçalarının süslenmesi için yöntem ve donatım ile buradan elde edilen ürünler
AU2003279429A8 (en) Diastereoselective method of preparing olefins by means of the horner-wadsworth-emmons reaction, comprising the addition of a tris-(polyoxaalkyl)-amine sequestering agent
WO2001073095A3 (en) Preparation of deoxynucleosides
DK1280752T3 (da) Fremgangsmåde til fremstilling af 2-alkyl-3-chlorphenoler
PT1064265E (pt) Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona
AU6584601A (en) Method for producing indols
GB9805808D0 (en) Process for producing meat products
TW200407314A (en) Preparation of 4, 6-dichloro-5-fluoropyrimidine
IL161800A0 (en) Method for the production of desclarithromycin, and intermediateproducts
YU53302A (sh) Postupci za pripremanje polimorfa klaritromicina
IL161079A0 (en) A strain of streptomyces flavidovirens and process for the manufacture of pravastatin utilizing the same
ZA200307447B (en) Process for the preparation of synthesis gas.